AG
IGC icon

Advisor Group’s IGC Pharma IGC Stock Holding History

Advisor Group’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$0 Hold
232
– – ﹤0.01% 5366
2019
Q3 		$0 Sell
232
-100
-30% -$120 ﹤0.01% 5331
2019
Q2 		$1K Sell
332
-1,000
-75% -$1.41K ﹤0.01% 5111
2019
Q1 		$3K Buy
+1,332
New +$3.03K ﹤0.01% 4845
2018
Q4 		– Sell
-5,232
Closed -$33K – 5155
2018
Q3 		$33K Buy
+5,232
New +$5.44K ﹤0.01% 3568

Other funds holding IGC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.77B AUM 9.47% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

Advisor Group's IGC Position: Q4 2019 in Review

Advisor Group held its IGC Pharma (IGC) position steady in Q4 2019 at 232 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5366.

Advisor Group first reported a position in IGC in Q3 2018 and has held it in 5 quarters since. The position peaked at $33K in Q3 2018. 26 funds tracked by Wall St. Rank hold IGC as of Q4 2019.

  • Advisor Group held 232 shares of IGC Pharma worth $0 as of Q4 2019.
  • Advisor Group left its IGC Pharma share count unchanged in Q4 2019.
  • IGC Pharma made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5366 holding.
  • Advisor Group first reported a position in IGC Pharma in Q3 2018 and has held it in 5 quarters since.
  • Advisor Group's IGC Pharma position peaked at $33K in Q3 2018.
  • 26 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.